Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
09 September 2021 - 6:30AM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
Michael Clayman, M.D., President and Chief Executive Officer, will
participate in a virtual analyst-led fireside chat at the H.C.
Wainwright 23rd Annual Global Investment Conference taking place
September 13-15, 2021.
The presentation will be available through an on-demand webcast
beginning at 7 a.m. ET on September 13, 2021, and will be
accessible on the Flexion website
at http://ir.flexiontherapeutics.com.
About Flexion TherapeuticsFlexion Therapeutics
(Nasdaq:FLXN) is a biopharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of people with musculoskeletal conditions, beginning with
osteoarthritis, the most common form of arthritis. The company's
core values are focus, ingenuity, tenacity, transparency and fun.
Please visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2024 to May 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Flexion Therapeutics Inc (NASDAQ): 0 recent articles
More News Articles